| human | Q5 |
| P269 | IdRef ID | 197613047 |
| P2798 | Loop ID | 56313 |
| P496 | ORCID iD | 0000-0002-2235-8682 |
| P1153 | Scopus author ID | 7004362382 |
| P214 | VIAF ID | 477145857082422921907 |
| P735 | given name | Matthew | Q4927231 |
| Matthew | Q4927231 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q41362598 | A Method for Characterizing the Type III Secretion System's Contribution to Pathogenesis: Homologous Recombination to Generate Yersinia pestis Type III Secretion System Mutants. |
| Q41391746 | A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis. |
| Q27304441 | Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure |
| Q44468465 | Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. |
| Q41362648 | Blue Native Protein Electrophoresis to Study the T3S System Using Yersinia pestis as a Model. |
| Q38697863 | Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement |
| Q51330865 | Detection of Protein Interactions in T3S Systems Using Yeast Two-Hybrid Analysis. |
| Q47964555 | Dissecting the structure of LcrV from Yersinia pestis, a truly unique virulence protein. |
| Q51330873 | Expression and Purification of N-Terminally His-Tagged Recombinant Type III Secretion Proteins. |
| Q22065462 | Genome sequence of Yersinia pestis KIM |
| Q57920108 | Identification of the Targets of Type III Secretion System Inhibitors |
| Q24815169 | Immunization of mice with YscF provides protection from Yersinia pestis infections |
| Q41362637 | In Vivo Photo-Cross-Linking to Study T3S Interactions Demonstrated Using the Yersinia pestis T3S System. |
| Q24797087 | Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface |
| Q40454924 | Introduction to Type III Secretion Systems. |
| Q40454912 | Isolation of Type III Secretion System Needle Complexes by Shearing. |
| Q33318974 | LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis |
| Q24548891 | LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis |
| Q51330870 | Mouse Immunization with Purified Needle Proteins from Type III Secretion Systems and the Characterization of the Immune Response to These Proteins. |
| Q36421545 | Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. |
| Q35671570 | Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice |
| Q36984033 | Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis. |
| Q41447992 | Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis. |
| Q38913922 | The N terminus of type III secretion needle protein YscF from Yersinia pestis functions to modulate innate immune responses |
| Q24801089 | The mechanisms responsible for 2-dimensional pattern formation in bacterial macrofiber populations grown on solid surfaces: fiber joining and the creation of exclusion zones |
| Q39550890 | Type III secretion needle proteins induce cell signaling and cytokine secretion via Toll-like receptors |
| Q63246295 | Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement |
Search more.